Research Progress of Acupoint Autohemotherapy in
Immune-Mediated Inflammatory Diseases

doi:10.1009-0959.2026.050024

Abstract

Abstract:

Immune-mediated inflammatory diseases （IMIDs） are a group of chronic inflammatory disorders induced by the interaction of genetic and environmental factors （such as infection， allergen exposure， and intestinal flora imbalance）， which trigger abnormal activation of the immune system and involve multiple tissues and organs. IMIDs include atopic dermatitis， psoriasis， asthma， rheumatoid arthritis， systemic lupus erythematosus， vitiligo， etc. The core pathogenesis of IMIDS involves the imbalance between innate and adaptive immunity， excessive activation of pro-inflammatory signaling pathways （such as IL-23/Th17， TLR/NF-κB）， and massive release of inflammatory factors （such as TNF-α， IL-4， IL-8）， which seriously endanger the life quality of patients. Conventional treatments mainly consists of immunosuppressants， steroid hormones， and biological agents， but they have limitations such as poor response， intolerance in some patients， and high costs. As a characteristic therapy combining meridian-acupoint stimulation and autohemotherapy， acupoint autohemotherapy （A-AHT） has gradually attracted attention in the treatment of IMIDs in recent years. This article aims to systematically review the research progress of A-AHT in IMIDs such as atopic dermatitis， psoriasis， asthma， and rheumatoid arthritis， and to analyze its immunomodulatory mechanisms of action， the efficacy of combined treatment applications， the improvement of prognosis in special populations， and the innovative progress in clinical applications. The article also summarize the deficiencies in current research and look forward to the future research directions of in-depth exploration of action targets and multi-center large-sample clinical verification， so as to provide a more comprehensive reference for further standardized application of A-AHT in IMIDs.

Key words: , Immune-mediated inflammatory diseases； , Acupoint autohemotherapy； , Atopic dermatitis； , Psoriasis； , Asthma

CLC Number:

DING Jiaqi1, ZHAO Daidi1, HUANG Yinan2, ZHAO Xuying1, REN Renle1, GUO Jun1.

Research Progress of Acupoint Autohemotherapy in Immune-Mediated Inflammatory Diseases [J]. CHINESE JOURNAL OF MEDICINAL GUIDE, 2026, 28(5): 573-573-577.

References

［1］ GBD 2019 IMID Collaborators. Global， regional， and national incidence of six major immune-mediated inflammatory diseases： findings from the global burden of disease study 2019［J］.eClin Med， 2023，64：102193.

［2］ Mcinnes IB， Gravallese EM. Immune-mediated inflammatory disease therapeutics： past， present and future［J］.Nat Rev Immunol， 2021，21（10）：680-686.

［3］ Monteleone G， Moscardelli A， Colella A， et al. Immune-mediated inflammatory diseases： common and different pathogenic and clinical features［J］.Autoimmun Rev， 2023，22（10）：103410.

［4］李俊雄.经络注血疗法治疗哮喘［M］.北京：人民卫生出版社，2017：158.

［5］卢玉忠，张银，林春国，等.银翘散加减联合穴位自血疗法治疗风热犯表型慢性荨麻疹的疗效观察［J］.中国典型病例大全，2025，19（1）：381-385.

［6］谢欢.宣肺通窍针法结合自血穴位注射治疗过敏性鼻炎的临床疗效及其对肠道菌群的影响［D］.南京：南京中医药大学，2021.

［7］ Yan SH， Chen Y， Huang ZQ， et al. Acupoint autohemotherapy attenuates DNCB-induced atopic dermatitis and activates regulatory T cells in BALB/c Mice［J］.J Inflamm Res， 2024，17：2839-2850.

［8］林锐辉，林中方，莫怀民，等.自血穴位注射联合雷公藤多甙片治疗寻常型银屑病的临床研究［J］.中国中医药现代远程教育，2019，17（7）：82-84.

［9］邓文，谢纬，颜绮.自血疗法治疗支气管哮喘的应用研究进展［J］.中国医药科学，2023，13（23）：56-59.

［10］胡莎，李金香，旷惠桃，等.自血穴位注射疗法结合中药治疗类风湿性关节炎临床观察［J］.新中医，2018，50（1）：108-111.

［11］左政，姜云武.自血穴位注射对系统性红斑狼疮免疫指标的影响［J］.针灸临床杂志，2012，28（3）：24-26.

［12］陈旭.自血疗法联合308 nm准分子激光治疗局限性白癜风的临床疗效观察［D］.呼和浩特：内蒙古医科大学，2021.

［13］管连城，杨凡，陈雨佳，等.基于肠道微生态探讨葛根芩连汤“从肠治皮”干预特应性皮炎的机制［J/OL］.中华中医药学刊，1-11［2025-10-13］.https：//link.cnki.net/urlid/21.1546.R.20250512.1631.006.

［14］ Savva M， Papadopoulos NG， Gregoriou S， et al. Recent advancements in the atopic dermatitis mechanism［J］.Front Biosci （Landmark Ed）， 2024，29（2）：84.

［15］ Wang B， Yu Z， Liu J， et al. IL-4-induced decrease in both the number and CTLA-4 expression of T（reg） impairs suppression of Th2 type inflammation in severe atopic dermatitis［J］.J Dermatol Sci， 2024，114（2）：54-63.

［16］ Jia T， Che D， Zheng Y， et al. Mast cells initiate type 2 inflammation through tryptase released by MRGPRX2/MRGPRB2 activation in atopic dermatitis［J］.J Invest Dermatol， 2024，144（1）：53-62.

［17］全小红，李树谦，李颖.陈秀华教授治疗特应性皮炎经验述要［J］.中国针灸，2017，37（3）：307-310.

［18］黄晋权.自血穴注对DNCB诱导Balb/c小鼠特应性皮炎免疫炎症的影响［D］.广州：南方医科大学，2021.

［19］ Zeng ZW， Huang JQ， Chen Y， et al. Acupoint autohemotherapy attenuates atopic dermatitis lesions by regulating Th1/Th2 balance in DNCB-induced BALB/c mice［J］.Chin J Integr Med， 2022，28（7）：612-619.

［20］潘婷华，曾丽霞，李惠贞，等.自血穴位注射治疗妊娠特应性皮疹临床观察［J］.中西医结合研究，2025，17（2）：115-117.

［21］史玉玲.《中国银屑病诊疗指南（2023版）》解读［J］.同济大学学报（医学版），2023，44（5）：631-633.

［22］李凤迪，王艳心，郭雯.自血疗法治疗寻常型银屑病的研究概述［J］.基层中医药，2022，1（12）：108-112.

［23］陈云龙，杨庆镗，林研研，等.自血穴位注射治疗银屑病118例［J］.中国中医药现代远程教育，2011，9（10）：41-42.

［24］陈云龙，林研研，陈珊珊，等.自血穴位注射治疗寻常型银屑病多中心疗效观察及对外周血IL-8、TNF-α的影响［J］.甘肃中医学院学报，2011，28（3）：48-50.

［25］吴波，程孝顶，曲善忠，等.自血疗法配合穴位埋线治疗寻常型银屑病90例疗效观察［J］.四川医学，2017，38（1）：10-12.

［26］中国中西医结合学会皮肤性病专业委员会色素病学组，中华医学会皮肤性病学分会白癜风研究中心，中国医师协会皮肤科医师分会色素病专委会.白癜风诊疗共识（2024版）［J］.中华皮肤科杂志，2024，57（12）：1065-1070.

［27］杨燕.自血注射疗法联合中药治疗局限性白癜风临床疗效观察［D］.南京：南京中医药大学，2017.

［28］牟青.中药联合火针及自血疗法治疗肢端型白癜风及皮肤镜下的观察［D］.济南：山东中医药大学，2020.

［29］佘江健，白宇乾，刘振敏.梅花针叩刺与生姜片涂擦联合自体静脉血患处皮下与穴位注射治疗白癜风观察［J］.实用中医内科杂志，2012，26（16）：78-79.

［30］李学良，许朝霞，王忆勤.支气管哮喘发病机制的研究进展［J］.中华中医药学刊，2012，30（9）：1960-1963.

［31］中华医学会呼吸病学分会.支气管哮喘防治指南（2024年版）［J］.中华结核和呼吸杂志，2025，48（3）：208-248.

［32］周龙健，顾凤群，王俏，等.自血疗法联合布地奈德福莫特罗治疗支气管哮喘的临床研究［J］.新中医，2024，56（18）：152-156.

［33］刘浩雷，向毅，焦海禄，等.自血穴位注射疗法对支气管哮喘患者Th1、Th2型细胞因子的影响［J］.深圳中西医结合杂志，2018，28（16）：165-166.

［34］曾梓苑.布地奈德混悬液联合自血疗法治疗支气管哮喘急性发作期的临床观察［D］.广州：广州中医药大学，2022.

［35］齐鑫.穴位注射治疗支气管哮喘选穴用药规律的文献研究［D］.沈阳：辽宁中医药大学，2021.

［36］王俊伟，李伟，耿兴超.类风湿关节炎发病机制研究进展［J］.风湿病与关节炎，2024，13（8）：67-72.

［37］ Figus FA， Piga M， Azzolin I， et al. Rheumatoid arthritis： extra-articular manifestations and comorbidities［J］.Autoimmun Rev， 2021，20（4）：102776.

［38］ Smolen JS， Landewe R， Bergstra SA， et al. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs： 2022 update［J］.Ann Rheum Dis， 2023，82（1）：3-18.

［39］代雨晴，熊浪，唐芳，等.中医药调控中性粒细胞治疗类风湿关节炎研究进展［J］.陕西中医，2024，45（11）：1576-1578， 1585.

［40］ Ameer M A， Chaudhry H， Mushtaq J， et al. An overview of systemic lupus erythematosus （SLE） pathogenesis， classification， and management［J］.Cureus， 2022，14（10）：e30330.

［41］陈文华，丁梦珍，马芹，等.新型靶向制剂和细胞免疫治疗系统性红斑狼疮研究进展［J］.医学理论与实践，2025，38（1）：49-52.

[1]	TANG Wanting, LI Feiyu, CHEN Hongmei, CHEN Haihong, ZHAI Huaqiang. Considerations on the Digital-Intelligent Development of the "Whole Lifecycle" of Traditional Chinese Medicine Preparations in Medical Institutions [J]. CHINESE JOURNAL OF MEDICINAL GUIDE, 2026, 28(5): 623-623-629.
[2]	WU Qingyan, ZHANG Qi, XU Xiaodan, LIU Lisha. Analysis of Supportive Policies for the Development of Domestic Innovative Drugs in China Based on a Three-Dimensional Analysis Framework [J]. CHINESE JOURNAL OF MEDICINAL GUIDE, 2026, 28(5): 630-630-638.
[3]	FU Yang, ZHENG Weiwei, ZHOU Fan, HUANG Li, YAN Zhifen, GENG Linlin, LIN Qifeng. Interference Studies of In Vitro Diagnostic Reagents Based on WS/T 356—2024 "Guideline for Evaluation of Commutability of Reference Materials" [J]. CHINESE JOURNAL OF MEDICINAL GUIDE, 2026, 28(5): 528-528-535.
[4]	ZHAO Chengli, PAN Weiwei, LU Lianni, MENG Hai, WU Xudong. Evaluation on Clinical Value of VA-dual Regimen versus B-quadruple Regimen in the Treatment of H. pylori Infection in Elderly Patients [J]. CHINESE JOURNAL OF MEDICINAL GUIDE, 2026, 28(5): 593-593-598.
[5]	GENG Yinglun, ZHOU Shijie, LI Yaohua. The Application and Challenges of Artificial Intelligence in Medical Device Evaluation [J]. CHINESE JOURNAL OF MEDICINAL GUIDE, 2026, 28(5): 516-516-521.
[6]	LIU Jijun, ZHANG Hui. Bioinformatics and Machine Learning-Based Analysis of Key Ferroptosis-Related Genes in Major Depressive Disorder [J]. CHINESE JOURNAL OF MEDICINAL GUIDE, 2026, 28(5): 558-558-567.
[7]	ZHANG Yu, YANG Weili, LI Jun, LI Cong, YU Lili. Study on the Efficacy of Qingjin Jianghuo Decoction Combined with FBAL in the Treatment of Severe Pneumonia with the Syndrome of Phlegm-Heat Obstructing the Lung [J]. CHINESE JOURNAL OF MEDICINAL GUIDE, 2026, 28(5): 599-599-604.
[8]	WANG Jiarui, LI Zihan, BAI Junwen. Prediction Model of Axillary Lymph Node Negative after NAC in HER-2 Positive Breast Cancer [J]. CHINESE JOURNAL OF MEDICINAL GUIDE, 2026, 28(5): 587-587-592.
[9]	WANG Yuqin, SONG Dengqin, ZHOU Dong, CHEN Hongci, ZHANG Xiong, ZHANG Meng. Research Progress on the Anti-Gastric Cancer Effects and Mechanisms of Astragaloside IV [J]. CHINESE JOURNAL OF MEDICINAL GUIDE, 2026, 28(5): 568-568-572.
[10]	YU Yue, DING Dandan, LI Min, SHU Ruiying, CHEN Zisu. Exploring the Treatment of Pediatric Guillain-Barré Syndrome from the Perspective of Lung Based on the Theory of Flaccidity Syndrome in the “Huangdi Neijing” [J]. CHINESE JOURNAL OF MEDICINAL GUIDE, 2026, 28(5): 617-617-622.
[11]	WANG Chao, PANG Tao, YANG Liyuan, TAO Xia, ZHANG Feng, CHEN Wansheng. Pharmacodynamics and Safety Evaluation of Shengxian Decoction in Treating Chronic Heart Failure [J]. CHINESE JOURNAL OF MEDICINAL GUIDE, 2026, 28(5): 548-548-557.
[12]	HUANG Simin, ZHANG Lu, DAI Lijuan, WANG Siyu, TAO Ke, ZHANG Xingxing, GAO Yating, LU Tingting. Exploring the Theory of "the Spleen as the Defender" in Diagnosing and Treating T Cell Exhaustion in Lung Cancer [J]. CHINESE JOURNAL OF MEDICINAL GUIDE, 2026, 28(5): 611-611-616.
[13]	FU Xueting, WU Xiaodong, ZHAO Mingfen. Effects of Qishenjiang Decoction on Serum Levels of VEGF， ADMA and sST2 in Patients with Chronic Heart Failure [J]. CHINESE JOURNAL OF MEDICINAL GUIDE, 2026, 28(5): 605-605-610.
[14]	ZHANG Chunqing, ZHOU Liangbin, JIANG Xiao, CAO Xiao, LI Meng, ZHU Jiong, LU Yong. Analysis on Classification and Definition of Medical Software Products Under the New EU Medical Device Regulations [J]. CHINESE JOURNAL OF MEDICINAL GUIDE, 2026, 28(5): 522-522-527.
[15]	LOU Jinghu, WU Zhineng, CHENG Yi, LI Meng, LIU Nan, WANG Zengming, GAO Xiang, ZHENG Aiping, ZHANG Hui. An Influenza Hemagglutinin mRNA Lipid Nanoparticle Vaccine Elicits Respiratory Mucosal Immunity [J]. CHINESE JOURNAL OF MEDICINAL GUIDE, 2026, 28(5): 536-536-547.

Research Progress of Acupoint Autohemotherapy in Immune-Mediated Inflammatory Diseases

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments